These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7363245)

  • 21. Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.
    Daugherty CK; Ratain MJ; Emanuel EJ; Farrell AT; Schilsky RL
    J Clin Oncol; 2008 Mar; 26(8):1371-8. PubMed ID: 18227527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dying for a cure. Why cancer patients often turn to risky, experimental treatments--and wind up paying with their lives.
    Kaplan S; Brownlee S
    US News World Rep; 1999 Oct; 127(14):34-7, 40-3. PubMed ID: 10621514
    [No Abstract]   [Full Text] [Related]  

  • 23. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
    Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
    J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Barriers to informed consent in clinical trials.
    Gallagher SM
    Ostomy Wound Manage; 1999 Nov; 45(11):14-6. PubMed ID: 10687654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical considerations in the design of clinical trials.
    Carter SK
    Cancer Treat Rep; 1980; 64(2-3):367-71. PubMed ID: 7407773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cancer chemoprevention.
    Hong WK; Lippman SM
    J Natl Cancer Inst Monogr; 1995; (17):49-53. PubMed ID: 8573453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The placebo problem. Individual and socio-ethical considerations on controlled therapeutic trials].
    Müller-Oerlinghausen B
    MMW Munch Med Wochenschr; 1983 Feb; 125(5):80-4. PubMed ID: 6405223
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical considerations in the treatment of breast cancer.
    Shingleton WW; Shingleton AB
    Cancer; 1980 Aug; 46(4 Suppl):1031-4. PubMed ID: 7397653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The conduct of therapeutic trials in cancer medicine.
    Rudnick S; Capizzi RL
    Semin Oncol; 1977 Jun; 4(2):255-8. PubMed ID: 327556
    [No Abstract]   [Full Text] [Related]  

  • 30. [Principles of therapeutic trials (author's transl)].
    Lellouch J
    Rev Fr Mal Respir; 1979; 7(4):427-8. PubMed ID: 549175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ethical principles and their practical significance in clinicopharmacological trials].
    Koch HJ; Klug B
    Dtsch Med Wochenschr; 1997 Feb; 122(7):205-9. PubMed ID: 9072492
    [No Abstract]   [Full Text] [Related]  

  • 32. [Methods for clinical study of antineoplastic drugs].
    Lichinitser MR
    Vopr Onkol; 1986; 32(8):93-8. PubMed ID: 3765515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Problems in testing new drugs in the hospital and general practice (phase III)].
    Blumenbach L
    Med Welt; 1981 Feb; 32(7):210-2. PubMed ID: 7207155
    [No Abstract]   [Full Text] [Related]  

  • 34. [Phase I studies as non-therapeutic trials in oncology].
    Brinkman-Woltjer LF; Vermorken JB; van Groeningen CJ; Gall HE; Pinedo HM
    Ned Tijdschr Geneeskd; 1988 Dec; 132(51):2321-5. PubMed ID: 3216917
    [No Abstract]   [Full Text] [Related]  

  • 35. Eligibility exclusions, losses to follow-up, removal of randomized patients, and uncounted events in cancer clinical trials.
    Gail MH
    Cancer Treat Rep; 1985 Oct; 69(10):1107-13. PubMed ID: 4042091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method to reduce loss to follow-up in clinical trials: informed, withdrawal of consent.
    Cleland JG; Torp-Pedersen C; Coletta AP; Lammiman MJ
    Eur J Heart Fail; 2004 Jan; 6(1):1-2. PubMed ID: 15012911
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical research in cancer chemotherapy.
    Gross J
    Oncol Nurs Forum; 1986; 13(1):59-65. PubMed ID: 3632861
    [No Abstract]   [Full Text] [Related]  

  • 38. [Methodology of clinical studies of myorelaxants].
    Blin O; Guieu R; Desnuelle C; Serratrice G
    Therapie; 1990; 45(3):267-71. PubMed ID: 2363115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ethical perspective in clinical trials for drug development].
    Fujiwara Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():693-700. PubMed ID: 25831850
    [No Abstract]   [Full Text] [Related]  

  • 40. [Principles of clinical tests of new drugs (author's transl)].
    Elis J
    Cesk Gynekol; 1973 Sep; 38(8):567-8. PubMed ID: 4587719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.